학술논문
A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor α biological treatments according to the current guidelines
Document Type
Academic Journal
Author
Source
ANNALS OF THE RHEUMATIC DISEASES. Sep 01, 2005 64(9):1383-1384
Subject
Language
English
ISSN
0003-4967